Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Equity (2021 - 2025)

Krystal Biotech's Return on Equity history spans 5 years, with the latest figure at 0.17% for Q4 2025.

  • For Q4 2025, Return on Equity rose 8.0% year-over-year to 0.17%; the TTM value through Dec 2025 reached 0.17%, up 8.0%, while the annual FY2025 figure was 0.19%, 9.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.17% at Krystal Biotech, down from 0.18% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.18% in Q3 2025 and bottomed at 0.27% in Q1 2023.
  • The 5-year median for Return on Equity is 0.01% (2023), against an average of 0.03%.
  • The largest annual shift saw Return on Equity dropped -12bps in 2022 before it skyrocketed 38bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.14% in 2021, then plummeted by -90bps to 0.26% in 2022, then surged by 105bps to 0.01% in 2023, then skyrocketed by 583bps to 0.1% in 2024, then surged by 79bps to 0.17% in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Return on Equity are 0.17% (Q4 2025), 0.18% (Q3 2025), and 0.14% (Q2 2025).